Retinoblastoma Phase II Expanded Access Clinical Trial (NCT06679634)
🩺 Plain-English Summary (8th-Grade Level)
In this research study investigators want to learn more about treatment of advanced or recurrent retinoblastoma. For children with retinoblastoma that have an advanced stage of presentation in one eye or if they have failed all conventional treatment, eye removal is considered. This study will investigate the utility of a chemoplaque(s) to salvage eyes involved with retinoblastoma. The goal of the study is to further determine/assess the safety and efficacy and optimal chemotherapy dose for retinoblastoma.
Who can join: Review the eligibility criteria below.
Location: NewYork Presbyterian Morgan Stanley Children's Hospital — New York, New York
Age range: Not specified to 8 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- NewYork Presbyterian Morgan Stanley Children's Hospital — New York, New York
- Children's Wisconsin — Milwaukee, Wisconsin
📞 Contact the Study Coordinator
Phone: (212) 305-0011
Email: bpm2133@cumc.columbia.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Retinoblastoma
- Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma — Memphis, Tennessee
- Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life — New York, New York
- Studying Health Outcomes After Treatment in Patients With Retinoblastoma — Chicago, Illinois
- Retinoblastoma Patient Clinical Database and Tissue Repository — Phoenix, Arizona
Explore by condition: All Retinoblastoma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.